Workgroup 2: human xenograft models of prostate ca...[Prostate. 1998] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Prostate. 1998 Jun 15;36(1):56-8. Links

Workgroup 2: human xenograft models of prostate cancer.

Stearns ME, Ware JL, Agus DB, Chang CJ, Fidler IJ, Fife RS, Goode R, Holmes E, Kinch MS, Peehl DM, Pretlow TG 2nd, Thalmann GN.

Department of Pathology, Medical College of Pennsylvania and Hahnemann University, Philadelphia 19129, USA.

PMID: 9650917 [PubMed - indexed for MEDLINE]

Related articles

Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.
J Natl Cancer Inst. 2003 Jul 2; 95(13):990-1000.

[J Natl Cancer Inst. 2003]
ReviewAnimal models of prostate cancer.
Methods Mol Med. 2003; 81:89-112.

[Methods Mol Med. 2003]
ReviewUse of animal models in defining efficacy of chemoprevention agents against prostate cancer.
Eur Urol. 1999; 35(5-6):459-63.

[Eur Urol. 1999]
Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.
Cancer Res. 1999 Oct 1; 59(19):4761-4.

[Cancer Res. 1999]
Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.
Int J Oncol. 1999 Mar; 14(3):501-8.

[Int J Oncol. 1999]
» See reviews... | » See all...

Cited by 1 PubMed Central article

Basic science of hormonal therapy for prostate cancer.
Peehl DM. Rev Urol. 2001; 3 Suppl 3:S15-22.

[Rev Urol. 2001]

Recent Activity

Clear Turn Off Turn On

Workgroup 2: human xenograft models of prostate cancer.Workgroup 2: human xenograft models of prostate cancer.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show